News Conference News EuroPCR 2021 Transradial PCI Bests Femoral Access in Complex Cases: COLOR Michael O'Riordan May 21, 2021
News Conference News EuroPCR 2021 Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN L.A. McKeown May 21, 2021
News Conference News EuroPCR 2021 Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances Caitlin E. Cox May 21, 2021
News Conference News EuroPCR 2021 Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry Todd Neale May 20, 2021
News Conference News EuroPCR 2021 COOL-AMI Fails to Show Benefit of Rapid Cooling in STEMI Yael L. Maxwell May 20, 2021
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Conference News EuroPCR 2021 CLASP 2-Year Data Promising for Pascal Transcatheter Mitral Repair Shelley Wood May 19, 2021
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News ACC 2021 Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’ Michael O'Riordan May 18, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 Hyperinvasive Approach May Boost Survival in OHCA Yael L. Maxwell May 18, 2021
News Conference News ACC 2021 RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients Todd Neale May 17, 2021
News Conference News ACC 2021 Lancet Commission on CVD in Women Aims to Slash Global Burden Shelley Wood May 17, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News ACC 2021 COVID-19 Doubled Burnout Rates in Cardiology Yael L. Maxwell May 17, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021